175 related articles for article (PubMed ID: 23603988)
1. Cdk9 phosphorylates Pirh2 protein and prevents degradation of p53 protein.
Bagashev A; Fan S; Mukerjee R; Claudio PP; Chabrashvili T; Leng RP; Benchimol S; Sawaya BE
Cell Cycle; 2013 May; 12(10):1569-77. PubMed ID: 23603988
[TBL] [Abstract][Full Text] [Related]
2. Transcriptional regulation of HIV-1 gene expression by p53.
Mukerjee R; Claudio PP; Chang JR; Del Valle L; Sawaya BE
Cell Cycle; 2010 Nov; 9(22):4569-78. PubMed ID: 21088492
[TBL] [Abstract][Full Text] [Related]
3. Differential response between the p53 ubiquitin-protein ligases Pirh2 and MdM2 following DNA damage in human cancer cells.
Duan W; Gao L; Wu X; Zhang Y; Otterson GA; Villalona-Calero MA
Exp Cell Res; 2006 Oct; 312(17):3370-8. PubMed ID: 16934800
[TBL] [Abstract][Full Text] [Related]
4. Interplay between MDM2, MDMX, Pirh2 and COP1: the negative regulators of p53.
Wang L; He G; Zhang P; Wang X; Jiang M; Yu L
Mol Biol Rep; 2011 Jan; 38(1):229-36. PubMed ID: 20333547
[TBL] [Abstract][Full Text] [Related]
5. Cdk9 phosphorylates p53 on serine 392 independently of CKII.
Claudio PP; Cui J; Ghafouri M; Mariano C; White MK; Safak M; Sheffield JB; Giordano A; Khalili K; Amini S; Sawaya BE
J Cell Physiol; 2006 Sep; 208(3):602-12. PubMed ID: 16741955
[TBL] [Abstract][Full Text] [Related]
6. Structural and functional comparison of the RING domains of two p53 E3 ligases, Mdm2 and Pirh2.
Shloush J; Vlassov JE; Engson I; Duan S; Saridakis V; Dhe-Paganon S; Raught B; Sheng Y; Arrowsmith CH
J Biol Chem; 2011 Feb; 286(6):4796-808. PubMed ID: 21084285
[TBL] [Abstract][Full Text] [Related]
7. Identification and characterization of two novel isoforms of Pirh2 ubiquitin ligase that negatively regulate p53 independent of RING finger domains.
Corcoran CA; Montalbano J; Sun H; He Q; Huang Y; Sheikh MS
J Biol Chem; 2009 Aug; 284(33):21955-21970. PubMed ID: 19483087
[TBL] [Abstract][Full Text] [Related]
8. Phosphatase PPM1A negatively regulates P-TEFb function in resting CD4(+) T cells and inhibits HIV-1 gene expression.
Budhiraja S; Ramakrishnan R; Rice AP
Retrovirology; 2012 Jun; 9():52. PubMed ID: 22727189
[TBL] [Abstract][Full Text] [Related]
9. p53 Stabilization and accumulation induced by human vaccinia-related kinase 1.
Vega FM; Sevilla A; Lazo PA
Mol Cell Biol; 2004 Dec; 24(23):10366-80. PubMed ID: 15542844
[TBL] [Abstract][Full Text] [Related]
10. TRIAD1 inhibits MDM2-mediated p53 ubiquitination and degradation.
Bae S; Jung JH; Kim K; An IS; Kim SY; Lee JH; Park IC; Jin YW; Lee SJ; An S
FEBS Lett; 2012 Sep; 586(19):3057-63. PubMed ID: 22819825
[TBL] [Abstract][Full Text] [Related]
11. The Establishment of a Hyperactive Structure Allows the Tumour Suppressor Protein p53 to Function through P-TEFb during Limited CDK9 Kinase Inhibition.
Albert TK; Antrecht C; Kremmer E; Meisterernst M
PLoS One; 2016; 11(1):e0146648. PubMed ID: 26745862
[TBL] [Abstract][Full Text] [Related]
12. Phosphorylation of Pirh2 by calmodulin-dependent kinase II impairs its ability to ubiquitinate p53.
Duan S; Yao Z; Hou D; Wu Z; Zhu WG; Wu M
EMBO J; 2007 Jul; 26(13):3062-74. PubMed ID: 17568776
[TBL] [Abstract][Full Text] [Related]
13. Pirh2, a ubiquitin E3 ligase, inhibits p73 transcriptional activity by promoting its ubiquitination.
Wu H; Zeinab RA; Flores ER; Leng RP
Mol Cancer Res; 2011 Dec; 9(12):1780-90. PubMed ID: 21994467
[TBL] [Abstract][Full Text] [Related]
14. RFWD3-Mdm2 ubiquitin ligase complex positively regulates p53 stability in response to DNA damage.
Fu X; Yucer N; Liu S; Li M; Yi P; Mu JJ; Yang T; Chu J; Jung SY; O'Malley BW; Gu W; Qin J; Wang Y
Proc Natl Acad Sci U S A; 2010 Mar; 107(10):4579-84. PubMed ID: 20173098
[TBL] [Abstract][Full Text] [Related]
15. C/EBPbeta regulates human immunodeficiency virus 1 gene expression through its association with cdk9.
Mameli G; Deshmane SL; Ghafouri M; Cui J; Simbiri K; Khalili K; Mukerjee R; Dolei A; Amini S; Sawaya BE
J Gen Virol; 2007 Feb; 88(Pt 2):631-640. PubMed ID: 17251582
[TBL] [Abstract][Full Text] [Related]
16. Kaposi's sarcoma-associated herpesvirus K-cyclin interacts with Cdk9 and stimulates Cdk9-mediated phosphorylation of p53 tumor suppressor.
Chang PC; Li M
J Virol; 2008 Jan; 82(1):278-90. PubMed ID: 17942552
[TBL] [Abstract][Full Text] [Related]
17. Novel CDK9 inhibitor oroxylin A promotes wild-type P53 stability and prevents hepatocellular carcinoma progression by disrupting both MDM2 and SIRT1 signaling.
Yao JY; Xu S; Sun YN; Xu Y; Guo QL; Wei LB
Acta Pharmacol Sin; 2022 Apr; 43(4):1033-1045. PubMed ID: 34188177
[TBL] [Abstract][Full Text] [Related]
18. Pirh2, a p53-induced ubiquitin-protein ligase, promotes p53 degradation.
Leng RP; Lin Y; Ma W; Wu H; Lemmers B; Chung S; Parant JM; Lozano G; Hakem R; Benchimol S
Cell; 2003 Mar; 112(6):779-91. PubMed ID: 12654245
[TBL] [Abstract][Full Text] [Related]
19. Induction of monocyte chemoattractant protein-1 (MCP-1/CCL2) gene expression by human immunodeficiency virus-1 Tat in human astrocytes is CDK9 dependent.
Khiati A; Chaloin O; Muller S; Tardieu M; Horellou P
J Neurovirol; 2010 Mar; 16(2):150-67. PubMed ID: 20370601
[TBL] [Abstract][Full Text] [Related]
20. p53 ubiquitination: Mdm2 and beyond.
Brooks CL; Gu W
Mol Cell; 2006 Feb; 21(3):307-15. PubMed ID: 16455486
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
